ATTENTION NASDAQ: RXST INVESTORS: Contact Berger Montague About an RxSight Class Action Lawsuit

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities between November 7, 2024, and July 8, 2025 [1][2] Company Overview - RxSight, headquartered in Aliso Viejo, CA, is a medical technology company that develops light adjustable intraocular lenses (LAL) used in cataract surgery [2] Legal Allegations - The lawsuit alleges that RxSight failed to disclose: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3] 2. Overstated demand for RxSight's products [3] 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3] Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance [4] - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4]